CH0329023102
CH0329023102
AC Immune SA
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 3.573.000 | 27.309.000 | 86.9% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 72.436.000 | 79.687.000 | 9.1% | |
| Operating Income | -68.863.000 | -52.378.000 | 31.5% |
| Pretax Income | -70.447.000 | -50.913.000 | 38.4% |
| Net Income Common Stockholders | -70.447.000 | -50.916.000 | 38.4% |
| -- | -- | -- | |
| -- | -- | -- |